EU-BASED LABORATORY · NAVARRA, SPAIN PEPTIDES-ONLY POLICY · OPEN METHOD IA-SOP-001 DATA AS PUBLISHED · SOURCES DATED
EN
Iberian AnalyticalIndependent peptide testing SECTION: LEARN · UPDATED SEPTEMBER 1, 2026

Home › Learn › Retatrutide testing

Retatrutide testing and certificate of analysis.

IA-TEST-003 · analyte page · updated September 1, 2026 · research use only

Triple GIP / GLP-1 / glucagon receptor agonist (LY3437943).

The short answer

Retatrutide is tested by reverse-phase HPLC (UV 214 nm): chromatographic purity plus duplicate quantification in mg per vial against a characterized in-house standard (no pharmacopoeial monograph exists). Identity is assessed by retention time against the same standard, with mass-spectrometry confirmation available as an add-on. €149 per vial, 48–72 h target turnaround, and every report verifiable.

What the analysis measures

Purity, quantity, identity

The complete method — column, gradient, wavelength, limits — is published on the open method page.

Reference parameters

The molecule on paper

Molecular weight≈4731 Da (published literature)
ClassTriple GIP / GLP-1 / glucagon receptor agonist (LY3437943).
Also seen asLY3437943
Tariff categoryGLP-1 & metabolic
Reference basisA characterized in-house standard (no pharmacopoeial monograph exists)

No public compound-database record exists for this analyte; values marked as literature are from the published scientific record. Your supplier's salt form and net-peptide content will differ from free-peptide values.

Worth knowing

Before you test Retatrutide

Retatrutide has no pharmacopoeial monograph and, at the time of writing, no public compound-database record — the reference is a characterized in-house standard: a lot we have characterized by mass spectrometry and assigned content to by mass balance. The certificate states this basis explicitly, together with the slightly wider quantification uncertainty it implies. When a monograph or official standard appears, the method moves to it and the change is versioned.

Price

€149 per vial, published

Retatrutide testing is €149 at the published rate — see its row in the price list. Add-ons: mass-spectrometry identity confirmation +€79 (adds 5–7 days), extended CoA data +€15, additional report +€29 (at order creation), rush +50%, additional vial of the same lot −30%.

On the certificate

What the CoA shows

New to certificates? Read how to read a peptide CoA and how to verify one.

FAQ

Retatrutide testing questions

Why does the retatrutide CoA say “characterized in-house standard”?

Because no pharmacopoeial reference standard exists for retatrutide yet. The laboratory characterizes its own reference lot by mass spectrometry and mass balance, states that on the certificate, and versions the method the day an official standard becomes available.

How much does Retatrutide testing cost?

€149 per vial at the published rate: chromatographic purity plus duplicate quantification in mg per vial, with a verifiable report. Mass-spectrometry identity confirmation is +€79, extended CoA data +€15, and an additional report +€29 at order creation.

How long does Retatrutide testing take?

The target turnaround is 48–72 hours from sample receipt. A rush option at +50% moves the sample to the front of the queue; the mass-spectrometry add-on adds 5–7 days.

Same category

Also tested in GLP-1 & metabolic

Semaglutide · Tirzepatide · Cagrilintide · Liraglutide · Survodutide — or see the full price list.

Iberian Analytical opens in Q1 2027 — from €99 per test, 48–72 h target, and every report verifiable. Nothing is sold on this site today. Leave an email and we will write once, when the laboratory starts issuing certificates.

Testing for a business? Apply for an associate account — a 24-month rate lock and priority scheduling.